Breast Implants: Lymphoma and Blood Cancer
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
The Law Offices of Thomas J. Lamb represents people who have been harmed by unsafe medical products, or the families of those who have died.
We are currently investigating breast implant cases that involve lymphoma and blood cancers.
In more detail, the US Food and Drug Administration (FDA) has received reports about women who have had breast implant procedures done and, later, were diagnosed with these medical conditions:
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- Anaplastic Large Cell Lymphoma (ALCL)
- Non-Hodgkin Lymphoma (also known as Non-Hodgkin’s Lymphoma, NHL, or just Lymphoma)
- T-cell Lymphoma
- Blood Cancer
We encourage you to submit a Breast Implants Cancer Case Review – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible breast implants case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience.
- Summary of Information
- The Disease
- FDA Information
- Frequently Asked Questions
➤ About the Disease
➤ Risk Factors
We are here to help the women and families who have experienced this unfortunate situation.
We have successfully handled personal injury and wrongful death cases for people throughout the country.
Our firm does not put its clients into large class actions lawsuits. Rather, an individual lawsuit is filed for each case.
There are no costs associated with having us review your possible breast implants case.
Be assured that the information you provide to our law firm is treated as strictly confidential.
Submitting a case evaluation does not obligate you to hire our law firm.
Lastly, we want you to know that you will get a reply directly from attorney Tom Lamb no later than the next business day.
Most Recent Article on This Topic
New Data Released on Risk of Lymphoma Due to Breast Implants
Since my last article on this topic, “What is the Risk of Death Due to Breast Implant-Associated Lymphoma?,” additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released.
The most recent study, titled “Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast,” was published on January 4, 2018, and comes from researchers who analyzed the population-based nationwide Dutch pathology registry.
To read more of this article, click below:
In this particular study, the goal was to “determine relative and absolute risks of breast-ALCL in women with breast implants.” In turn, the researchers hoped that their findings would facilitate more accurate evidence-based counseling about implants between doctors and patients.
Confirmation of Facts
Much of the information found in this new study is not, in fact, new. Like previous studies on BIA-ALCL, this article found that textured implants are associated with BIA-ALCL, while smooth implants do not appear to be. These researchers also found that 82% of the women in the study with BIA-ALCL had “macrotextured” implants, while the remaining 18% had “microtextured” implants.
This information confirms previous theories that the textured surface of the breast implant provides a place for the bacteria to stick, and more surface area on the implant aids in the growth and proliferation of that bacteria. For this and other theories on how BIA-ALCL develops, see “Breast Implants and Lymphoma: Who’s to Blame?”
The results of the Dutch researchers also echoed those of previous studies as regards the relatively low overall risk of developing BIA-ALCL after breast implants. Based on their findings, they estimated that for women who get breast implants, the risk of developing BIA-ALCL is as follows:
- At age 50: 1 in 35,000
- At age 70: 1 in 12,000
- At age 75: 1 in 7,000
Application of Findings
While they acknowledged that the absolute risk was low, researchers encouraged doctors to closely monitor their breast implant patients for any signs of BIA-ALCL. They also strongly suggested that doctors discuss the risk of BIA-ALCL with patients who are considering breast implants.
Lastly, they point out that their conclusions suggest a need for:
[I]ncreased awareness [of BIA-ALCL] among the public, medical professionals, and regulatory bodies, promotion of alternative cosmetic procedures, and alertness to signs and symptoms of breast-ALCL in women with implants….[as well as] increased clinical awareness, comprehensive registration of implants and complications, and stimulation of alternative cosmetic/reconstructive procedures.
We will continue to monitor the medical literature concerning breast implants and this rare type of lymphoma, and report on new information as it becomes available.
Written by: Heather Helmendach, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.
Our earlier articles about this breast implants lymphoma cancer situation:
- Breast Implant-Associated Lymphoma Diagnoses on the Rise
- What is the Risk of Death Due to Breast Implant-Associated Lymphoma?
- Treatments For Breast Implants Associated Lymphoma And Blood Cancer
- Breast Implants and Lymphoma: Who’s to Blame?
- Breast Implants Lymphoma Cancer: Diagnosis And Treatment Developments
- Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
- March 2017 FDA Report: Breast Implants Linked To Lymphoma Blood Cancer
- Breast Implants Linked to Rare Lymphoma Blood Cancer